Is biopsy-proven cellular rejection an important clinical consideration in heart transplantation?

Current Opinion in Cardiology

Volumn 20, Issue 2, 2005, Pages 127-131

  Kirklin, James K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Allograft coronary artery disease; Endomyocardial biopsy; Heart transplantation; Mycophenolate; Rejection; Tacrolimus

Indexed keywords

CORTICOSTEROID;

APOPTOSIS; CARDIAC ALLOGRAFT VASCULOPATHY; CELLULAR REJECTION; GRAFT REJECTION; GRAFT SURVIVAL; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; INFLAMMATORY CELL; PEDIATRIC SURGERY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR;

BIOPSY, NEEDLE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 15344346540     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000153950.49813.d2     Document Type: Review

References (17)

1. Caves PK, Stinson EB, Billingham ME. Serial transvenous biopsy of the transplanted human heart. Lancet 1974; 2:821-826.
2. Konno S, Sekiguchi M, Sakakibara S. Catheter biopsy of the heart. Radiol Clin North Am 1971; 9:491-510.
3. Sakakibara S, Konno S. Endomyocardial biopsy. Jpn Heart J 1962; 3: 537-543.
4. Billingham ME. Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transplant 1982; 1:25-30.
5. Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Lung Transplant 1990; 9:587-593.
6. Levi DS, DeConde AS, Fishbein MC, et al. The yield of surveillance endomyocardial biopsies as a screen for cellular rejection in pediatric heart transplant patients. Pediatr Transplant 2004; 8:22-28.
7. Garrity ER Jr, Mehra MR. An update on clinical outcomes in heart and lung transplantation. Transplantation 2004; 77:S68-S74. This review article traces developments over the past decade in maintenance immunosuppression, rescue therapy for acute rejection, and drug combination strategies in heart and lung transplantation.
8. Delgado JF, Sanchez V, de la Calzada CS, et al. Impact of diltiazem administration and cyclosporine levels on the incidence of acute rejection in heart transplant patients. Transpl Int 2003; 16:676-680.
9. Chin C, Naftel DC, Singh TP, et al. PHTS: risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant 2004; 23:178-185. Recurrent rejection is a risk factor for mortality after pediatric heart transplantation, particularly when complicated by hemodynamic compromise.
10. Klingenberg R, Koch A, Schnable PA, et al. Allograft rejection of ISHLT grade ≥3a occurring late after heart transplantation-a distinct entity? J Heart Lung Transplant 2003; 22:1005-1013. In an adult heart transplant experience, late rejection is not associated with adverse outcome.
11. Yamani MH, Yousufuddin M, Starling RC, et al. Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant 2004; 23:272-276. In the absence of fibrosis on endomyocardial biopsy, a higher cumulative biopsy score correlated with greater coronary maximal intimal thickness by ultrasound.
12. Valentine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 2004; 23:3187-3193. This overview discusses relevant recent literature regarding genesis, risk factors, and management of allograft coronary artery disease.
13. Vassalli G, Gallino A, Weis M. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Eur Heart J 2003; 24:1180-1188.
14. Masri SC, Yamani MH, Russell MA, et al. Sustained apoptosis in human cardiac allografts despite histologic resolution of rejection. Transplantation 2003; 76:859-864. Increased apoptosis of inflammatory cells in the endomyocardium occurs during and after rejection in the presence of corticosteroid therapy.
15. Arnau-Vives MA, Almenar L, Hervas I, et al. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant 2004; 23:850-856.
16. Rosenthal DN, Chin C, Nishimura K, Perry SAB. Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data. J Heart Lung Transplant 2004; 23:373-379. Echocardiographic and hemodynamic parameters are not sufficiently discriminatory to replace cardiac biopsy in the identification of cellular rejection.
17. Asante-Korang A, Fickey M, Boucek MM, Boucek RJ Jr. Diastolic performance assessed by tissue Doppler after pediatric heart transplantation. J Heart Lung Transplant 2004; 23:865-872.